5-173890134-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_030627.4(CPEB4):c.401G>A(p.Arg134Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000309 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
CPEB4
NM_030627.4 missense
NM_030627.4 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 7.76
Genes affected
CPEB4 (HGNC:21747): (cytoplasmic polyadenylation element binding protein 4) Enables RNA binding activity. Predicted to be involved in several processes, including cellular response to glucose starvation; negative regulation of cytoplasmic translation; and response to ischemia. Located in cytoplasm and nucleus. Biomarker of liver cirrhosis; portal hypertension; and primary biliary cholangitis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.21617565).
BS2
High AC in GnomAd4 at 34 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPEB4 | NM_030627.4 | c.401G>A | p.Arg134Lys | missense_variant | 1/10 | ENST00000265085.10 | NP_085130.2 | |
CPEB4 | NM_001308189.2 | c.401G>A | p.Arg134Lys | missense_variant | 1/9 | NP_001295118.1 | ||
CPEB4 | NM_001308191.2 | c.401G>A | p.Arg134Lys | missense_variant | 1/8 | NP_001295120.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPEB4 | ENST00000265085.10 | c.401G>A | p.Arg134Lys | missense_variant | 1/10 | 1 | NM_030627.4 | ENSP00000265085 | ||
CPEB4 | ENST00000334035.9 | c.401G>A | p.Arg134Lys | missense_variant | 1/9 | 1 | ENSP00000334533 | A1 | ||
CPEB4 | ENST00000520867.5 | c.401G>A | p.Arg134Lys | missense_variant | 1/8 | 1 | ENSP00000429092 | P4 | ||
CPEB4 | ENST00000519835.5 | c.401G>A | p.Arg134Lys | missense_variant | 1/7 | 1 | ENSP00000429048 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251164Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135810
GnomAD3 exomes
AF:
AC:
36
AN:
251164
Hom.:
AF XY:
AC XY:
21
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000317 AC: 464AN: 1461842Hom.: 0 Cov.: 33 AF XY: 0.000290 AC XY: 211AN XY: 727222
GnomAD4 exome
AF:
AC:
464
AN:
1461842
Hom.:
Cov.:
33
AF XY:
AC XY:
211
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74346
GnomAD4 genome
AF:
AC:
34
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
17
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.401G>A (p.R134K) alteration is located in exon 1 (coding exon 1) of the CPEB4 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the arginine (R) at amino acid position 134 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D
Sift4G
Benign
T;T;T;T
Polyphen
P;P;P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at